{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T23:28:25Z","timestamp":1723591705507},"reference-count":30,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.1248\/bpb.b21-00007","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T22:12:09Z","timestamp":1619820729000},"page":"701-706","source":"Crossref","is-referenced-by-count":1,"title":["Rapid Increase of Gastrointestinal P-Glycoprotein Functional Activity in Response to Etoposide Stimulation"],"prefix":"10.1248","volume":"44","author":[{"given":"Kentaro","family":"Yano","sequence":"first","affiliation":[{"name":"Laboratory of Drug Metabolism and Pharmacokinetics, Yokohama University of Pharmacy"},{"name":"Laboratory of Biopharmaceutics, Department of Pharmacology, Takasaki University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kimura","sequence":"additional","affiliation":[{"name":"Laboratory of Biopharmaceutics, Department of Pharmacology, Takasaki University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Laboratory of Biopharmaceutics, Department of Pharmacology, Takasaki University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Ogihara","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ogihara T, Mizoi K, Kamioka H, Yano K. Physiological roles of ERM proteins and transcriptional regulators in supporting membrane expression of efflux transporters as factors of drug resistance in cancer. <i>Cancers<\/i>, <b>12<\/b>, 3352 (2020).","DOI":"10.3390\/cancers12113352"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Yano K, Tomono T, Ogihara T. Advances in studies of P-glycoprotein and its expression regulators. <i>Biol. Pharm. Bull.<\/i>, <b>41<\/b>, 11\u201319 (2018).","DOI":"10.1248\/bpb.b17-00725"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Yano K, Seto S, Kamioka H, Mizoi K, Ogihara T. Testosterone and androstenedione are endogenous substrates of P-glycoprotein. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>520<\/b>, 166\u2013170 (2019).","DOI":"10.1016\/j.bbrc.2019.09.067"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Yano K, Tomono T, Sakai R, Kano T, Morimoto K, Kato Y, Ogihara T. Contribution of radixin to P-glycoprotein expression and transport activity in mouse small intestine <i>in vivo.<\/i> <i>J. Pharm. Sci.<\/i>, <b>102<\/b>, 2875\u20132881 (2013).","DOI":"10.1002\/jps.23637"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Morishita H, Okawa K, Ishii M, Mizoi K, Ito M, Arakawa H, Yano K, Ogihara T. Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein. <i>PLOS ONE<\/i>, <b>15<\/b>, e0232438 (2020).","DOI":"10.1371\/journal.pone.0232438"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Latorre R, Huynh J, Mazzoni M, Gupta A, Bonora E, Clavenzani P, Chang L, Mayer EA, De Giorgio R, Sternini C. Expression of the bitter taste receptor, T2R38, in enteroendocrine cells of the colonic mucosa of overweight\/obese <i>vs.<\/i> lean subjects. <i>PLOS ONE<\/i>, <b>11<\/b>, e0147468 (2016).","DOI":"10.1371\/journal.pone.0147468"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yano K, Mita S, Morimoto K, Haraguchi T, Arakawa H, Yoshida M, Yamashita F, Uchida T, Ogihara T. Multiple linear regression analysis indicates association of P-glycoprotein substrate or inhibitor character with bitterness intensity, measured with a sensor. <i>J. Pharm. Sci.<\/i>, <b>104<\/b>, 2789\u20132794 (2015).","DOI":"10.1002\/jps.24232"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yano K, Shimizu S, Tomono T, Ogihara T. Gastrointestinal hormone cholecystokinin increases P-glycoprotein membrane localization and transport activity in Caco-2 cells. <i>J. Pharm. Sci.<\/i>, <b>106<\/b>, 2650\u20132656 (2017).","DOI":"10.1016\/j.xphs.2017.04.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Loo TW, Clarke DM. Nonylphenol ethoxylates, but not nonylphenol, are substrates of the human multidrug resistance P-glycoprotein. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>247<\/b>, 478\u2013480 (1998).","DOI":"10.1006\/bbrc.1998.8823"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Silva R, Sousa E, Carmo H, Palmeira A, Barbosa DJ, Gameiro M, Pinto M, Bastos MdeL, Remiao F. Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquat. <i>Arch. Toxicol.<\/i>, <b>88<\/b>, 937\u2013951 (2014).","DOI":"10.1007\/s00204-014-1193-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kobori T, Harada S, Nakamoto K, Tokuyama S. Time-dependent changes in the activation of RhoA\/ROCK and ERM\/p-ERM in the increased expression of intestinal P-glycoprotein by repeated oral treatment with etoposide. <i>J. Pharm. Sci.<\/i>, <b>102<\/b>, 1670\u20131682 (2013).","DOI":"10.1002\/jps.23503"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kobori T, Harada S, Nakamoto K, Tokuyama S. Changes in PtdIns(4,5)P2 induced by etoposide treatment modulates small intestinal P-Glycoprotein <i>via<\/i> radixin. <i>Biol. Pharm. Bull.<\/i>, <b>37<\/b>, 1124\u20131131 (2014).","DOI":"10.1248\/bpb.b13-00953"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Jeon TI, Seo YK, Osborne TF. Gut bitter taste receptor signaling induces ABCB1 through a mechanism involving CCK. <i>Biochem. J.<\/i>, <b>438<\/b>, 33\u201337 (2011).","DOI":"10.1042\/BJ20110009"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Yano K, Todokoro I, Kamioka H, Tomono T, Ogihara T. Functional alterations of multidrug resistance-associated proteins 2 and 5, and breast cancer resistance protein upon Snail-induced epithelial\u2013mesenchymal transition in HCC827 cells. <i>Biol. Pharm. Bull.<\/i>, <b>44<\/b>, 103\u2013111 (2021).","DOI":"10.1248\/bpb.b20-00693"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tomono T, Yano K, Ogihara T. Snail-induced epithelial-to-mesenchymal transition enhances P-gp-mediated multidrug resistance in HCC827 cells. <i>J. Pharm. Sci.<\/i>, <b>106<\/b>, 2642\u20132649 (2017).","DOI":"10.1016\/j.xphs.2017.03.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Meng Z, Le Marchand S, Agnani D, Szapacs M, Ellens H, Bentz J. Microvilli morphology can affect efflux active P-glycoprotein in confluent MDCKII-hMDR1-NKI and Caco-2 cell monolayers. <i>Drug Metab. Dispos.<\/i>, <b>45<\/b>, 145\u2013151 (2017).","DOI":"10.1124\/dmd.116.072157"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nakano T, Sekine S, Ito K, Horie T. Ezrin regulates the expression of Mrp2\/Abcc2 and Mdr1\/Abcb1 along the rat small intestinal tract. <i>Am. J. Physiol. Gastrointest. Liver Physiol.<\/i>, <b>305<\/b>, G807\u2013G817 (2013).","DOI":"10.1152\/ajpgi.00187.2013"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yano K, Okabe C, Fujii K, Kato Y, Ogihara T. Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines. <i>J. Pharm. Pharmacol.<\/i>, <b>72<\/b>, 575\u2013582 (2020).","DOI":"10.1111\/jphp.13225"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kamioka H, Tomono T, Fujita A, Onozato R, Iijima M, Tsuchida S, Arai T, Fujita Y, Zhang X, Yano K, Ogihara T. Moesin-mediated P-glycoprotein activation during snail-induced epithelial\u2013mesenchymal transition in lung cancer cells. <i>J. Pharm. Sci.<\/i>, <b>109<\/b>, 2302\u20132308 (2020).","DOI":"10.1016\/j.xphs.2020.03.008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yano K, Otsuka K, Kato Y, Kawabata H, Ohmori S, Arakawa H, Ogihara T. Different regulation of P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin, radixin and moesin proteins. <i>J. Pharm. Pharmacol.<\/i>, <b>68<\/b>, 361\u2013367 (2016).","DOI":"10.1111\/jphp.12525"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Tomono T, Otsuka K, Yano K, Kanagawa M, Arakawa H, Ogihara H. Recommended daily dose of sesame lignans has no influence on oral absorption of P-glycoprotein substrates in rats. <i>Biol. Pharm. Bull.<\/i>, <b>38<\/b>, 1960\u20131963 (2015).","DOI":"10.1248\/bpb.b15-00392"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Tomono T, Machida T, Kamioka H, Shibasaki Y, Yano K, Ogihara T. Entinostat reverses P-glycoprotein activation in snail-overexpressing adenocarcinoma HCC827 cells. <i>PLOS ONE<\/i>, <b>13<\/b>, e0200015 (2018).","DOI":"10.1371\/journal.pone.0200015"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Troutman MD, Thakker DR. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells. <i>Pharm. Res.<\/i>, <b>20<\/b>, 1192\u20131199 (2003).","DOI":"10.1023\/A:1025096930604"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Dabrowski A, Groblewski GE, Schafer C, Guan KL, Williams JA. Cholecystokinin and EGF activate a MAPK cascade by different mechanisms in rat pancreatic acinar cells. <i>Am. J. Physiol.<\/i>, <b>273<\/b>, C1472\u2013C1479 (1997).","DOI":"10.1152\/ajpcell.1997.273.5.C1472"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Piiper A, Elez R, You SJ, Kronenberger B, Loitsch S, Roche S, Zeuzem S. Cholecystokinin stimulates extracellular signal regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon. <i>J. Biol. Chem.<\/i>, <b>278<\/b>, 7065\u20137072 (2003).","DOI":"10.1074\/jbc.M211234200"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Tong J, Li L, Ballermann B, Wang Z. Phosphorylation and activation of RhoA by ERK in response to epidermal growth factor stimulation. <i>PLOS ONE<\/i>, <b>11<\/b>, e0147103 (2016).","DOI":"10.1371\/journal.pone.0147103"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S, Tsukita S. Rho-kinase phosphorylates COOH-terminal threonines of ezrin\/radixin\/moesin (ERM) proteins and regulates their head-to-tail association. <i>J. Cell Biol.<\/i>, <b>140<\/b>, 647\u2013657 (1998).","DOI":"10.1083\/jcb.140.3.647"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Kobori T, Harada S, Nakamoto K, Tokuyama S. Activation of ERM-family proteins <i>via<\/i> RhoA\u2013ROCK signaling increases intestinal P-gp expression and leads to attenuation of oral morphine analgesia. <i>J. Pharm. Sci.<\/i>, <b>102<\/b>, 1095\u20131105 (2013).","DOI":"10.1002\/jps.23441"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Borgnia MJ, Eytan GD, Assaraf YG. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. <i>J. Biol. Chem.<\/i>, <b>271<\/b>, 3163\u20133171 (1996).","DOI":"10.1074\/jbc.271.6.3163"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Lagas JS, Fan L, Wagenaar E, Vlaming ML, van Tellingen O, Beijnen JH, Schinkel AH. P-Glycoprotein (P-gp\/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide. <i>Clin. Cancer Res.<\/i>, <b>16<\/b>, 130\u2013140 (2010).","DOI":"10.1158\/1078-0432.CCR-09-1321"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/5\/44_b21-00007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T03:37:03Z","timestamp":1619840223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/5\/44_b21-00007\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b21-00007","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}